WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) between March 17, 2021 and May 7, 2024, both…
LRP-661's data highlights its superior safety, efficacy, bioavailability, and PK in multiple species. Furthermore, LRP-661's oral formulation ability compared to cannabidiol, marks a significant advancement in the field of epilepsy…
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ:MRNS) between…
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 29% to $2.36 during Monday’s session after the company effected a 1-for-32 reverse stock split of its common stock. The company says this move aimed to raise the…
"With all three of our core programs in the clinic, we believe we have solidified a strong foundation and are poised for our next exciting chapter as a company. To best position Centessa for this pivotal time, we've added key new talent to…
The National Agency for Food and Drug Administration Control (NAFDAC), has signed a pact with the Ministry of Food and Drug Safety (MFDS) in Seoul, South Korea. Speaking at the signing of the Memorandum of Understanding (MoU) in South…
The National Agency for Food and Drug Administration Control (NAFDAC), has signed Memorandum of Understanding (MoU), with Ministry of Food and Drug Safety (MFDS) Seoul, South Korea.
Priya Bhambi, 40, of Brookline, pleaded guilty in US District Court in Boston to one count of conspiracy to commit wire fraud and three counts of wire fraud, prosecutors said Thursday.
ABU DHABI, UAE , June 7, 2024 /PRNewswire/ -- During BIO International Convention 2024, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Abu Dhabi Investment Office (ADIO), Etihad…
(NaturalNews) If you have ever wondered why only certain pharmaceutical products and methods are used in, for example, the treatment of cancer, the answer has to...
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Marinus Pharmaceuticals, Inc. ("Marinus" or the …
Investors who purchased the Company's securities between March 17, 2021 and May 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 5, 2024.